Scientists explore promising new option for first line of attack in lymphoma
2/26/2014
A study led by Manchester scientists has shown promising results for a new treatment approach in follicular lymphoma.Follicular lymphoma is a type of non-Hodgkin's lymphoma, a blood cancer, that usually develops slowly. The majority of patients are diagnosed when their disease is at an advanced stage.
Novel blood screen reveals the risk of dying among healthy people
2/26/2014
A new screening technology reveals a signature of mortality in blood samples. Researchers have identified four biomarkers that help to identify people at high risk of dying from any disease within the next five years.Researchers from Finland and Estonia have discovered novel biological markers that are strongly indicative of risk of dying from any disease within the near future.
In an analysis that included more than two million patients who underwent a percutaneous coronary intervention (PCI; procedures such as balloon angioplasty or stent placement used to open narrowed coronary arteries), there was considerable variation in red blood cell transfusion practices among hospitals across the U.S.
Research could help improve early diagnosis of prostate cancer
2/26/2014
Prostate cancer patients could get better diagnosis and treatment for the disease in the future thanks to a successful research project at the University of Essex.Currently, is it difficult to distinguish between benign and aggressive malignant tumours, meaning some prostate cancer patients are unnecessarily "over-treated" which can lead to needless distress and anxiety.
More intensive radiotherapy is better than less for localised prostate cancer
2/26/2014
A radiotherapy regime involving higher doses of radiation is a better option than having lower doses for men with localised prostate cancer, the 10-year results of the largest trial of its kind have shown.
Bristol-Myers Squibb has expressed its disappointment that the National Institute for Health and Care Excellence (NICE) has issued draft guidance which effectively denies access to Yervoy®q (ipilimumab) for NHS patients with previously-untreated advanced (unresectable or metastatic) melanoma, not involved in clinical trials.
Scientists explore promising new option for first line of attack in lymphoma
2/26/2014
A study led by Manchester scientists has shown promising results for a new treatment approach in follicular lymphoma.Follicular lymphoma is a type of non-Hodgkin's lymphoma, a blood cancer, that usually develops slowly. The majority of patients are diagnosed when their disease is at an advanced stage.
Novel blood screen reveals the risk of dying among healthy people
2/26/2014
A new screening technology reveals a signature of mortality in blood samples. Researchers have identified four biomarkers that help to identify people at high risk of dying from any disease within the next five years.Researchers from Finland and Estonia have discovered novel biological markers that are strongly indicative of risk of dying from any disease within the near future.
In an analysis that included more than two million patients who underwent a percutaneous coronary intervention (PCI; procedures such as balloon angioplasty or stent placement used to open narrowed coronary arteries), there was considerable variation in red blood cell transfusion practices among hospitals across the U.S.
Fast and effective mechanism devised to combat ovarian cancer
2/26/2014
Ovarian cancer accounts for more deaths of American women than any other cancer of the female reproductive system. According to the American Cancer Society, one in 72 American women will be diagnosed with ovarian cancer, and one in 100 will ultimately die of the condition.Now Prof.